Bybit launches 24/7 perpetuals for major currency pairs
Bybit added USDTsettled perpetuals tracking EUR/USD, GBP/USD and USD/JPY, with 24/7 trading and leverage of up to 100x. Source：Cointelegraph
Why a stronger Japanese currency could spell trouble for AI and technology stocks
A rapid unwind of the Japanese yen ‘carry trade’ could trigger a stock selloff, particularly hurting highvaluation U.S. tech names. Source：MarketWatch
A contrarian case for stock-market gains through the midterm election
Yet another lease on life for the bull market, observes Mark Hulbert. Source：MarketWatch
SpaceX’s stock could jump 43% — if the company is able to accomplish this engineering feat
Failing to successfully scale the Starship rocket would make SpaceX’s plans a lot more difficult. Source：MarketWatch
Visa brings onchain credit to its growing stablecoin card business
Visa is combining VisaNet settlement data with blockchain lending as stablecoin payment volume on its network jumps nearly 200% year over year.…
These software stocks are in a prime spot to benefit from a rapidly shifting AI landscape
Adobe tops a list of software companies ranked by cash generation, while sector heavyweights Microsoft and Oracle are at the bottom. Source：MarketWatch
Intel’s stock is rising as the company looks primed to boost prices even more
The chip maker is reportedly set to further lift prices on its PC chips as costs rise across the supply chain. Source：MarketWatch
Oracle’s stock gets a boost as the OpenAI ecosystem comes back into favor
“It looks like OpenAI is turning things around,” and that’s seen as good news for Oracle, which has a lot riding on the ChatGPT creator’s success.…
Strive’s SATA nears $1 billion market cap as Strategy’s STRC continues to underperform
SATA’s 13% annualised dividend and resilience around par are helping Strive raise capital and outperform Strategy. Source：CoinDesk
Visa combines VisaNet data with onchain lending to power stablecoin card working capital
Visa's stablecoin settlement volume surpassed a $20 billion annualized run rate, up 15x year over year. Now it wants blockchain lenders to use that data to…
Novartis’s failed trial for cholesterol drug leads to broad biopharma selloff
Along with several other drugmakers, Novartis has bet that lowering Lp(a) will cut the risk of sometimes fatal cardiovascular events. Source：MarketWatch
Bitmine buys 28k ETH, completes 97% of treasury accumulation goal
While Bitmine’s completed 97% of its goal to acquire 5% of Ether’s supply, Tom Lee’s team faces a $5.1 billion unrealized loss on its main treasury asset.…